Linde PLC $LIN Stock Holdings Increased by Johnson Investment Counsel Inc.

Johnson Investment Counsel Inc. raised its position in shares of Linde PLC (NASDAQ:LIN) by 21.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,612 shares of the basic materials company’s stock after buying an additional 2,189 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Linde were worth $5,997,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in LIN. Darwin Wealth Management LLC bought a new position in Linde during the second quarter worth $25,000. Marquette Asset Management LLC bought a new stake in Linde during the third quarter valued at $27,000. YANKCOM Partnership raised its holdings in shares of Linde by 195.2% during the third quarter. YANKCOM Partnership now owns 62 shares of the basic materials company’s stock worth $29,000 after purchasing an additional 41 shares during the period. Guerra Advisors Inc bought a new position in shares of Linde in the 3rd quarter worth about $30,000. Finally, Albion Financial Group UT boosted its holdings in shares of Linde by 87.8% in the 3rd quarter. Albion Financial Group UT now owns 77 shares of the basic materials company’s stock valued at $37,000 after buying an additional 36 shares during the period. Institutional investors and hedge funds own 82.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on LIN shares. CICC Research initiated coverage on shares of Linde in a research report on Wednesday, December 3rd. They set an “outperform” rating and a $510.00 price objective for the company. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $516.00 target price on shares of Linde in a report on Monday, November 3rd. UBS Group raised their price target on Linde from $500.00 to $550.00 and gave the stock a “buy” rating in a report on Friday. Mizuho set a $525.00 price objective on Linde in a research report on Friday. Finally, Royal Bank Of Canada dropped their target price on Linde from $540.00 to $490.00 and set an “outperform” rating on the stock in a research report on Friday, December 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Linde presently has a consensus rating of “Moderate Buy” and an average price target of $508.20.

Linde Stock Performance

LIN opened at $460.51 on Wednesday. The company has a current ratio of 0.88, a quick ratio of 0.74 and a debt-to-equity ratio of 0.52. The business’s 50 day moving average is $433.10 and its 200-day moving average is $447.31. The stock has a market cap of $215.04 billion, a PE ratio of 31.56, a price-to-earnings-growth ratio of 3.00 and a beta of 0.84. Linde PLC has a twelve month low of $387.78 and a twelve month high of $486.38.

Linde (NASDAQ:LIN) last posted its earnings results on Thursday, February 5th. The basic materials company reported $4.20 EPS for the quarter, beating the consensus estimate of $4.18 by $0.02. The firm had revenue of $8.76 billion for the quarter, compared to analysts’ expectations of $8.64 billion. Linde had a return on equity of 19.52% and a net margin of 20.30%.The firm’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm earned $3.97 EPS. Linde has set its Q1 2026 guidance at 4.200-4.300 EPS and its FY 2026 guidance at 17.400-17.900 EPS. On average, analysts predict that Linde PLC will post 16.54 earnings per share for the current year.

About Linde

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher‑value specialty and electronic gases.